Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a 2-YearOld Child with Abdominopelvic Rhabdomyosarcoma: A Case Report of Anaesthetic Concerns
PDF
Cite
Share
Request
Case Report
P: 68-71
February 2022

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a 2-YearOld Child with Abdominopelvic Rhabdomyosarcoma: A Case Report of Anaesthetic Concerns

Turk J Anaesthesiol Reanim 2022;50(1):68-71
1. Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
No information available.
No information available
Received Date: 21.08.2020
Accepted Date: 22.10.2020
PDF
Cite
Share
Request

ABSTRACT

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a well-established multimodal treatment in patients with peritoneal surface malignancies in adults. Children younger than 3 years rarely undergo such extensive surgeries with heated chemotherapy infusion intraoperatively. Only one such case is reported in the literature for CRS-HIPEC for an abdominopelvic rhabdomyosarcoma in a child of 2 years or less. We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.

Keywords: Chemotherapy, children, cytoreductive surgery, hyperthermic, paediatrics, rhabdomyosarcoma

References

2024 ©️ Galenos Publishing House